Ted Love

Ted Love

Director/Board Member at GILEAD SCIENCES, INC.

Net worth: 4 M $ as of 2026-05-30

67 year
Health Technology
Commercial Services
Consumer Services

Profile

Dr. Ted W.
Love
, MD, is an Independent Director at Gilead Sciences, Inc., an Independent Director at Structure Therapeutics, Inc. and a Lead Independent Director at Royalty Pharma Plc.
He is on the Board of Directors at Jazz Pharmaceuticals Plc, Gilead Sciences, Inc., Structure Therapeutics, Inc., Royalty Pharma Plc, Avillion LLP, Biotechnology Innovation Organization and Life Science Cares Bay Area.
Dr. Love was previously employed as an Independent Director by Seagen, Inc., an Independent Director by Portola Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Global Blood Therapeutics, Inc., an Independent Director by CASCADIAN THERAPEUTICS INC, an Independent Director by Mast Therapeutics, Inc., an Independent Director by Amicus Therapeutics, Inc., an Independent Director by Bio-Rad Laboratories, Inc., an Executive VP, Head-Research & Development by Onyx Pharmaceuticals, Inc., a Lead Independent Director by KaloBios Pharmaceuticals, Inc., an Independent Director by Affymax, Inc., an Independent Director by Santarus, Inc., a Chairman, President & Chief Executive Officer by Nuvelo, Inc., a Senior Vice President-Development by Theravance, Inc., a Senior Vice President-Development by Theravance Biopharma Us LLC, and a VP-Product Development & Regulatory Affairs by Genentech, Inc. He also served on the board at Anesiva, Inc., ARCA biopharma, Inc., California Institute for Regenerative Medicine, ARCA biopharma, Inc. /Old/, California Healthcare Institute, Predix Pharmaceuticals, Inc., Stanford Health Care-Stanford Hospital and The Biotechnology Institute.
He received his undergraduate degree from Haverford College and a doctorate degree from Yale School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-04 58,393 ( 0.01% ) 3 M $ 2026-05-30
2026-04-29 5,484 ( 0% ) 737 214 $ 2026-05-30
2026-02-25 1,527 ( 0% ) 361 120 $ 2026-05-30
2026-04-19 0 ( -.--% ) - $ 2026-05-30

Ted Love active positions

CompaniesPositionStart
ROYALTY PHARMA PLC Director/Board Member 2020-07-29
STRUCTURE THERAPEUTICS INC. Director/Board Member 2023-08-02
GILEAD SCIENCES, INC. Director/Board Member 2024-01-31
JAZZ PHARMACEUTICALS PLC Director/Board Member 2025-11-30
Life Science Cares Bay Area
Director/Board Member -
Director/Board Member 2024-12-31
Director/Board Member 2013-07-21

Former positions of Ted Love

CompaniesPositionEnd
SEAGEN INC. Director/Board Member 2023-12-13
GLOBAL BLOOD THERAPEUTICS, INC. Chief Executive Officer 2022-10-04
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Ted Love's experience

Training of Ted Love

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

32

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Life Science Cares Bay Area

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!